Schedule 13G ownership disclosure
JASPER THERAPEUTICS INC
Security class unavailable · CUSIP: 471871103
Event date: 2023-01-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-019178
- Form type
- SC 13G
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Jan 30, 2023
- Reporting period
- Jan 27, 2023
- Description
- Schedule 13G beneficial ownership